Enlitic is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis.

Enlitic leverages the collective knowledge of the medical community to derive insights from billions of clinical cases to enable more accurate diagnoses, faster.

Enlitic was founded in Aug 4, 2014 & is based San Francisco and serves customers around the world.

Enlitic is shaping the next generation of diagnostic healthcare tools to help patients around the globe. By using AI and deep learning, the company helps Radiologists identify diseases and medical issues (e.g cancers and tumors) more accurately and earlier. 

Enlitic’s first product interprets chest x-rays, triaging normal from abnormal scans, and detecting and characterizing more than 40 distinct abnormalities such as cardiomegaly, lung nodules, and pneumothorax. Its unique algorithms bring together medical images, text and other data sources to operationalize data assets.


Enlitic is backed by Marubeni, Capitol Health, Amplify Partners, Data Collective and others. The company addded another $25M to its Series B on Nov 14, 2019, the round was closed with $15M on Apr 4, 2019. Bringing the total funding raised in Series B to $40M. And the brings Enliitic's total funding to $55M to date.


Enlitic was named as one of the "50 Smartest Companies in 2015" by MIT Tech Review.



  • Year founded: 2014
  • Funding Info: $55M over 5 Rounds (Latest Funding Type: Series B extension)
  • Yearly Revenue: $5M-$10M (2019)
  • Employee Size: 11-50
  • Business Valuation: Unknown
  • City/Town: San Francisco
  • State: California
  • Country: United States
Related businesses